Sino Biopharmaceutical Gains Approval for Cancer Drug
Sino Biopharmaceutical (HK:1177) has released an update.Pick the best stocks and maximize your portfolio:Discover top-rated stocks from highly ...
Nature21 年
Gabexate Mesilate (FOY) as a New Additional Therapy to High Dose Intravenous Gammaglobulin ...
Objective: Although high dose gammaglobulin (IVGG) associated with aspirin became the standards in the therapy for Kawasaki disease (KD), the coronary complications still occur about 10 percent of ...